$0.80
+0.12 (+17.65%)
Open$0.70
Previous Close$0.68
Day High$0.90
Day Low$0.68
52W High$18.88
52W Low$0.78
Volume—
Avg Volume3.21M
Market Cap26.64M
P/E Ratio—
EPS$-7.19
SectorBiotechnology
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 50.13M | 157.90M | 31.57M |
| Net Income | -215,285,819 | -610,259,014 | 932.2K |
| Profit Margin | -429.4% | -408.0% | 3.0% |
| EBITDA | -142,840,479 | -427,396,708 | 1.58M |
| Free Cash Flow | — | — | 483.5K |
| Rev Growth | -68.3% | -68.3% | +6.0% |
| Debt/Equity | 0.19 | 0.19 | 0.73 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $294.45 | -0.18% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $467.06 | -0.22% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $167.95 | -1.05% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $542.62 | -0.81% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $951.19 | -0.86% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $156.65 | -2.00% | 7.7 | 20.98B |